NCBIO Annual Meeting 2019
Name:
NCBIO Annual Meeting 2019
Date:
October 3, 2019
Time:
8:00 AM - 3:00 PM EDT
Registration:
Sorry, member registration for this event is closed.
Event Description:
As of September 27, registration is at capacity but NCBIO members can be placed on a wait list. Please sign up online and you will automatically be placed on the wait list. Contact Amber Niebauer, Events Director, at aniebauer@ncbioscience.net if you have any questions. If you are a nonmember, please contact Laura Gunter, Membership Director, at lgunter@ncbioscience.net.
The 25th Annual Meeting program also features a Networking Break and Lunch, and NCBIO Business Session.
TWO KEYNOTES:
New Innovations: Personalized Health and Cancer Treatment
Industry leader describes why these innovations have developed now, discusses the promise of the therapies, and highlights pricing and value.
This keynote discusses best strategies to raise funding, the impact of current regulations on product pricing, and the ability of companies to continue to innovate. Take a deep dive into the economics of the life science space and the economic cross currents that industry is navigating.
Access and Availability
This interactive session features a discussion of policies necessary to make both novel and established therapies accessible to patients. Learn more about the realities and responsive policies that are maturing or effecting patient access including value-based reimbursement, pharmaceutical rebate reform, and other important topics.
This discussion will take us from acknowledging the microbiome to understanding how to manipulate it for nutritional and therapeutic purposes.
Thank you to our sponsors.
Platinum: BIO, Bioventus, Cook Medical, and VWR
Gold: BDO, FUJIFILM Diosynth Biotechnologies, Grifols, LaSalle Group / Mentor Technical Group, and Novo Nordisk
Silver: AdvaMed, Charter Medical, Office Depot, The Conafay Group, UCB
Bronze: ALT, Business Wire, G1 Therapeutics, GSK, IQVIA, Liquidia Technologies, Mispro Biotech Services, Nikon, Novozymes, Thermo Fisher Scientific, UniFirst/UniClean
The 25th Annual Meeting program also features a Networking Break and Lunch, and NCBIO Business Session.
TWO KEYNOTES:
New Innovations: Personalized Health and Cancer Treatment
Industry leader describes why these innovations have developed now, discusses the promise of the therapies, and highlights pricing and value.
- Martin Murphy, DMedSc, Ph.D., FASCO, Founding Chief Executive Officer, CEO Roundtable on Cancer and Project Data Sphere
This keynote discusses best strategies to raise funding, the impact of current regulations on product pricing, and the ability of companies to continue to innovate. Take a deep dive into the economics of the life science space and the economic cross currents that industry is navigating.
- Peter Meath, Co-Head of Healthcare Banking, J.P. Morgan
- Lauren Ruane, Co-Head of Healthcare Banking, J.P. Morgan
Access and Availability
This interactive session features a discussion of policies necessary to make both novel and established therapies accessible to patients. Learn more about the realities and responsive policies that are maturing or effecting patient access including value-based reimbursement, pharmaceutical rebate reform, and other important topics.
- Dora Hughes, M.D., M.P.H., Associate Research Professor, Department of Health Policy and Management, Milken Institute School of Public Health, The George Washington University
- Jeff Kiser, Market Head of Sales and Service, Aetna
- Robin Levy, Senior Director, Public Policy and Advocacy, International Myeloma Foundation
- Marianne Lopez, Ph.D., Research Director, Value-Based Payment Reform, Duke-Margolis Center for Health Policy (Moderator)
- Vadim Lubarsky, Executive Director, CMS Policy and Reimbursement, Novartis
- Reginald Munden, D.M.D., M.D., Interim Vice President Clinical Operations and Cancer Services, Wake Forest Baptist Health
This discussion will take us from acknowledging the microbiome to understanding how to manipulate it for nutritional and therapeutic purposes.
- Anne Ballou, Ph.D., Research and Development Scientist, Premex Innovation Labs
- Jared Jensen, Ph.D., Nematologist, AgBiome
- John Ryals, Ph.D., Former President and Chief Executive Officer, Metabolon; Chair Emeritus, Board of Directors, Metabolon; Board of Directors, AgBiome (Moderator)
- Jorge Signes, Ph.D., Director, Operations and Genomics, David H. Murdock Research Institute
Thank you to our sponsors.
Platinum: BIO, Bioventus, Cook Medical, and VWR
Gold: BDO, FUJIFILM Diosynth Biotechnologies, Grifols, LaSalle Group / Mentor Technical Group, and Novo Nordisk
Silver: AdvaMed, Charter Medical, Office Depot, The Conafay Group, UCB
Bronze: ALT, Business Wire, G1 Therapeutics, GSK, IQVIA, Liquidia Technologies, Mispro Biotech Services, Nikon, Novozymes, Thermo Fisher Scientific, UniFirst/UniClean
